265107-45-7 Usage
Chemical structure
A pyridine derivative with a pyrrolidin-1-yl substituent
Physical state
Yellow solid at room temperature
Potential applications
Pharmaceutical industry, particularly in the area of central nervous system disorders
Structural features
Contains both a pyridine ring and a ketone functional group
Synthesis utility
Versatile building block for the synthesis of other organic compounds
Research status
Further research and investigation are needed to fully understand the properties and potential uses of the compound
Check Digit Verification of cas no
The CAS Registry Mumber 265107-45-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,5,1,0 and 7 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 265107-45:
(8*2)+(7*6)+(6*5)+(5*1)+(4*0)+(3*7)+(2*4)+(1*5)=127
127 % 10 = 7
So 265107-45-7 is a valid CAS Registry Number.
265107-45-7Relevant articles and documents
Pyridopyrimidine analogues as novel adenosine kinase inhibitors
Zheng, Guo Zhu,Lee, Chih-Hung,Pratt, John K.,Perner, Richard J.,Jiang, Mei Qun,Gomtsyan, Arthur,Matulenko, Mark A.,Mao, Yui,Koenig, John R.,Kim, Ki H.,Muchmore, Steve,Yu, Haixia,Kohlhaas, Kathy,Alexander, Karen M.,McGaraughty, Steve,Chu, Katharine L.,Wismer, Carol T.,Mikusa, Joseph,Jarvis, Michael F.,Marsh, Kennan,Kowaluk, Elizabeth A.,Bhagwat, Shripad S.,Stewart, Andrew O.
, p. 2071 - 2074 (2001)
A novel series of pyridopyrimidine analogues 9 was identified as potent adenosine kinase inhibitors based on the SAR and computational studies. Substitution of the C7 position of the pyridopyrimidino core with C2′ substituted pyridino moiety increased the in vivo potency and enhanced oral bioavailability of these adenosine kinase inhibitors.